|
Synonyms: compound 41 [PMID: 26704267] | Ruiming® (China) | SHR-4640 | SHR4640
ruzinurad is an approved drug
Compound class:
Synthetic organic
Comment: Ruzinurad (SHR-4640) is a selective, orally bioavailable urate anion exchanger 1 (URAT1; SLC22A12) inhibitor [2].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Lin Y, Chen X, Ding H, Ye P, Gu J, Wang X, Jiang Z, Li D, Wang Z, Long W et al.. (2021)
Efficacy and safety of a selective URAT1 inhibitor SHR4640 in Chinese subjects with hyperuricaemia: a randomized controlled phase II study. Rheumatology (Oxford), 60 (11): 5089-5097. [PMID:33693494] |
|
2. Peng J, Hu Q, Gu C, Liu B, Jin F, Yuan J, Feng J, Zhang L, Lan J, Dong Q et al.. (2016)
Discovery of potent and orally bioavailable inhibitors of Human Uric Acid Transporter 1 (hURAT1) and binding mode prediction using homology model. Bioorg Med Chem Lett, 26 (2): 277-282. [PMID:26704267] |
|
3. Shirley M. (2026)
Ruzinurad: First Approval. Drugs, [Epub ahead of print]. [PMID:42850557] |